Cookson Peirce & Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
AIM
AAMU
AAIS
BCAM
JWM
Cookson Peirce & Co's DGX Position: Q2 2026 in Review
Cookson Peirce & Co reduced its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, selling an estimated $148K and leaving 155,589 shares worth $33M. The position accounts for 1.09% of the portfolio, ranked #24.
Cookson Peirce & Co first reported a position in DGX in Q2 2016 and has held it in 12 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Cookson Peirce & Co held 155,589 shares of Quest Diagnostics worth $33M as of Q2 2026.
- Cookson Peirce & Co sold 753 Quest Diagnostics shares in Q2 2026, an estimated $148K.
- Quest Diagnostics made up 1.09% of Cookson Peirce & Co's portfolio in Q2 2026, its #24 holding.
- Cookson Peirce & Co first reported a position in Quest Diagnostics in Q2 2016 and has held it in 12 quarters since.
- 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.